IDH1 and oligodendroglioma: Apart from GBM IDH-wildtype, TERTp mutations have been described in almost 100% of oligodendrogliomas, 80–90% of molecular/non-molecular GBM IDH-wildtype, and 7% of IDH mutant astrocytomas [10,12,23].